FOXM1 expression was then determined by qRT-PCR and immunohistochemistry (IHC) in 60 pairs of colon cancer tissues and matched normal tissues, and the results revealed that FOXM1 was upregulated in colon cancer (Fig. 1i, j), which is in line with the RNA sequencing data from The Cancer Genome Atlas (TCGA) Colon Adenocarcinoma database (Fig. 1k). Here, FOXM1 is linked to colon adenocarcinoma.